Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Old API Wind-down Ltd - Ordinary Shares
ARLZQ
Healthcare
Drug Manufacturers - Major
Drug Manufacturers - Specialty & Generic
"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently...
operates in two geographical markets, the United States and Canada. The firm generates most of its reven
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCPK:ARLZQ)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
GoldenDilemma
X
View Profile
View Bullboard History
Comment by
GoldenDilemma
on May 10, 2017 11:35am
RE:RE:The Cost of Not Taking Your Medicine
lol
(189)
•••
biggerr
X
View Profile
View Bullboard History
Comment by
biggerr
on May 10, 2017 11:12am
RE:The Cost of Not Taking Your Medicine
we should be moving back into the $2's, it looks like ARZ will survive contrary to what shorts are saying
Lahontan Completes Phase Two of 2024 Drilling at Santa Fe
posted Jun 25, 2024 9:00am by
Lahontan Gold Corp.
-
|
"Lahontan is excited to complete the second Phase of our 2024 drilling campaign at Santa Fe. The drilling was completed rapidly and under budget, a tribute to our geologic team and the excellent drill crew. Work on the PEA continues at an accelerating pace, with site visits, scoping studies on capex and operating costs underway. We will continue to update investors as the PEA progresses and when assay results from the 2024 drilling program are received". ...read more
(61)
•••
snootchybootchy
X
View Profile
View Bullboard History
Post by
snootchybootchy
on May 10, 2017 7:18am
The Cost of Not Taking Your Medicine
I listened to the conference call last night and learned that the number of patients that do not fill their prescriptions of Yosprala is triple the rate of other branded cardiovascular drugs.
...more
(189)
•••
biggerr
X
View Profile
View Bullboard History
Comment by
biggerr
on May 10, 2017 1:27am
RE:RE:RE:Bold and Aggressive
That's what Bloom and Burton or whatever their name is, say in their analysis of ARZ from a few weeks ago, you can check this board, I posted a link to their article
(0)
•••
kuatolives
X
View Profile
View Bullboard History
Comment by
kuatolives
on May 09, 2017 8:57pm
RE:RE:Bold and Aggressive
So.... Merck spent all that money bringing zontivity to market, beat their heads against the wall trying to sell scripts etc etc, couldn't do it, tried again, failed again, and nobody thought of
...more
(189)
•••
biggerr
X
View Profile
View Bullboard History
Comment by
biggerr
on May 09, 2017 8:05pm
RE:Bold and Aggressive
by "label" he probably meant targeting it for the PAD crowd while Merck was targeting the ACS crowd who already were getting lots of similar drugs and didn't need additional
...more
(0)
•••
kuatolives
X
View Profile
View Bullboard History
Post by
kuatolives
on May 09, 2017 7:19pm
Bold and Aggressive
Listened to the CC. What a joke. Adams must have used the words"Bold and Aggressive" 100 times. Sounded like a greasy politician. Best question: "What differentiates your Zontivity
...more
(189)
•••
biggerr
X
View Profile
View Bullboard History
Comment by
biggerr
on May 09, 2017 6:08pm
RE:RE:RE:RE:RE:88 Cents tomorrow
you're right, the PPI alone in Yos costs much more than $10
(61)
•••
snootchybootchy
X
View Profile
View Bullboard History
Comment by
snootchybootchy
on May 09, 2017 4:09pm
RE:RE:RE:RE:88 Cents tomorrow
I tihnk you read that incorrectly. That $10/month is just the co-pay. Been too busy today to listen to the conference call but the financials were surprisingly good. The cash burn
...more
(0)
•••
kuatolives
X
View Profile
View Bullboard History
Comment by
kuatolives
on May 09, 2017 2:20pm
RE:RE:RE:RE:88 Cents tomorrow
They could also easily go straight to zero with a bullet.
(189)
•••
biggerr
X
View Profile
View Bullboard History
Comment by
biggerr
on May 09, 2017 12:54pm
RE:RE:RE:88 Cents tomorrow
actually their guidance could be conservative because at $10/month Yosprala is just about the same price as regular aspirin but with the PPI in it to prevent aspirin from burning a hole in your
...more
(0)
•••
kuatolives
X
View Profile
View Bullboard History
Comment by
kuatolives
on May 09, 2017 11:54am
RE:RE:88 Cents tomorrow
I like how their new direction (this time) is to concentrate on the Canadian market. You mean Tribute products?! Wow. What a bunch of effing geninuses.
(3)
•••
Floridas2000
X
View Profile
View Bullboard History
Comment by
Floridas2000
on May 09, 2017 8:18am
RE:88 Cents tomorrow
My bet is 50 cents by the end of the week!
(189)
•••
biggerr
X
View Profile
View Bullboard History
Comment by
biggerr
on May 09, 2017 12:52am
RE:RE:88 Cents tomorrow
$2.50 by Friday
(189)
•••
biggerr
X
View Profile
View Bullboard History
Comment by
biggerr
on May 09, 2017 12:49am
RE:88 Cents tomorrow
$2 tomorrow on good Zon sales guidanca, haaaaaaa
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Undervalued Oil & Gas Play Readies for Strong H2 2024 with Canadian and US Assets
How a truck transportation and logistics company leverages acquisitions and technology
High-grade gold potential in the world’s best mining jurisdiction